Crystal's MCW Coder Hub🧠 CPT Code 64644 — Chemodenervation of One Extremity; 5 or More Muscle(s)
Quick Reference
📋 Clinical Description
CPT 64644 describes the percutaneous injection of a chemical neurolytic agent — most commonly botulinum toxin A or B — into five or more muscles of a single extremity to treat spasticity or focal limb dystonia. It is the higher-complexity counterpart to 64642, which captures treatment of only 1-4 muscles in the first extremity. 64644 is used when the clinical presentation requires more extensive neuromuscular intervention — diffuse flexor or extensor synergy patterns, multi-joint spasticity, or complex posturing that cannot be adequately addressed with four or fewer injection targets.
64644 is the base (primary) code and must always represent the extremity with the greatest number of muscles injected in a given session. When multiple extremities are treated in the same encounter, CPT parenthetical guidance directs the coder to assign the primary code to the limb with the most muscles injected, regardless of which limb is treated first procedurally. For example, if the right upper extremity receives injections into 6 muscles and the left upper extremity receives injections into 3 muscles, 64644 is the primary code for the right upper extremity and add-on code 64643 is reported for the left upper extremity — not 64642 as primary.
This procedure may be performed in the following clinical contexts:
- Post-stroke upper limb flexor synergy — extensive involvement of the shoulder, elbow, wrist, and finger flexor groups requiring 5+ distinct muscle injections
- Post-stroke lower limb spasticity — gastrocnemius, soleus, tibialis posterior, flexor digitorum longus, flexor hallucis longus, and others contributing to equinus or scissoring gait
- Cerebral palsy, spastic quadriplegia or diplegia — diffuse multi-muscle involvement per extremity commonly necessitating 64644 rather than 64642
- Traumatic brain injury / spinal cord injury — extensive upper or lower motor neuron dysfunction driving complex limb posturing across multiple muscle groups
- Multiple sclerosis — progressive lower limb spasticity involving multiple muscle groups bilaterally
- Focal limb dystonia — task-specific dystonia with diffuse muscle involvement across a single extremity
🔬 Clinical & Anatomical Considerations
| Extremity Pattern | Common 5+ Muscle Scenario | Primary Indication |
|---|---|---|
| Upper Limb — Full Flexor Synergy | Pectoralis major, biceps brachii, brachialis, pronator teres, flexor carpi radialis, flexor digitorum superficialis | Post-stroke arm posturing with shoulder adduction, elbow/wrist flexion, finger curling |
| Upper Limb — Wrist/Hand Dominant | Flexor carpi radialis, flexor carpi ulnaris, flexor digitorum superficialis, flexor digitorum profundus, adductor pollicis, flexor pollicis longus | Clenched fist, thumb-in-palm deformity |
| Lower Limb — Equinus + Spastic Gait | Gastrocnemius (medial + lateral heads as 2 muscles if documented), soleus, tibialis posterior, flexor digitorum longus, flexor hallucis longus | Equinovarus foot, toe-curling, scissoring gait |
| Lower Limb — Stiff Knee + Hip | Rectus femoris, medial hamstrings, lateral hamstrings, iliopsoas, adductor longus, adductor magnus | Stiff-knee gait, hip adductor spasticity, scissoring |
Clinical Pearl — Muscle Count is the Entire Game
The split between 64642 and 64644 — and between 64643 and 64645 — hinges entirely on the muscle count. The boundary is at 5 muscles: 1-4 = the lower-tier code; 5 or more = the higher-tier code. The injecting physician’s note must explicitly name each muscle injected — not just the anatomic region or the number of injection sites. “Injected lower extremity spasticity muscles” is not a valid muscle count. If the note names 5 distinct muscles, 64644 is supported. If it names 4, 64642 is the correct code. Never infer or upgrade the muscle count from clinical context alone.
✅ Procedure Includes
- Pre-injection assessment of muscle tone, spasticity grade, and identification of all target muscles for the session
- Needle placement into 5 or more named muscles of the single target extremity, percutaneous
- Injection of botulinum toxin or other chemical neurolytic agent into each targeted muscle
- Needle repositioning within the same muscle for multi-site delivery (does not constitute additional muscles)
- Basic post-injection monitoring and patient instructions
- Documentation of: all muscles injected by name, muscle count, laterality, agent used, dose per muscle, and clinical rationale
✅ Separately Reportable (Not Included)
- 95874 — Needle EMG guidance for chemodenervation injection; list separately in addition to 64644; one unit per extremity where EMG is used; do not report 95873 and 95874 together
- 76942 — Ultrasonic guidance for needle placement; list separately when real-time ultrasound is used; permanent image documentation required
- J0585 — OnabotulinumtoxinA (Botox), per unit
- J0586 — AbobotulinumtoxinA (Dysport), per 5 units
- J0587 — RimabotulinumtoxinB (Myobloc), per 100 units
- J0588 — IncobotulinumtoxinA (Xeomin), per unit
Drug Billing Note
The botulinum toxin drug (J0585-J0588) is always billed as a separate line item from the procedure code. The J-code units must match the total documented administered dose, not the number of muscles or extremities. A 200-unit Botox injection = 200 units of J0585, regardless of how many muscles or extremities were treated. Discrepancies between the procedure note dose and the billed J-code units are a targeted audit finding.
❌ Excludes / Do Not Report Together
| Code | Description | Relationship to 64644 |
|---|---|---|
| 64642 | Chemodenervation of one extremity; 1-4 muscle(s) | Mutually exclusive with 64644 for the same extremity — when 5 or more muscles are injected in the primary limb, 64644 fully captures that work; do NOT report both for the same limb |
| 64615 | Chemodenervation; muscle(s) innervated by facial, trigeminal, cervical spinal, and accessory nerves | CPT parenthetical guidelines explicitly prohibit reporting 64615 in conjunction with 64644 |
| 64616 | Chemodenervation of neck muscle(s), excluding laryngeal muscles | Different anatomic region; separately reportable when neck and extremity chemodenervation are performed in the same session with supporting documentation of distinct sites |
| 64646 | Chemodenervation of trunk muscle(s); 1-5 muscle(s) | Trunk muscles are a distinct anatomic domain from extremity muscles; separately reportable when both trunk and extremity injections occur in the same session |
Never report 64642 and 64644 for the same extremity in the same session. When 5 or more muscles of a single extremity are injected, 64644 is the correct and only primary code for that limb — it fully subsumes the work. Reporting both codes for the same limb constitutes unbundling and will trigger NCCI edits. If the encounter involves two different extremities — one with 1-4 muscles and one with 5+ muscles — use 64644 as primary (for the 5+ muscle limb) and 64643 as the add-on (for the 1-4 muscle limb).
🌳 Code Tree — Destruction by Neurolytic Agent (Extremity Chemodenervation)
CPT 64600-64681 Surgery: Destruction by Neurolytic Agent
│
├── 64612-64617 Chemodenervation — Head, Neck, Larynx
│ ├── 64612 Chemodenervation; facial nerve muscle(s), unilateral
│ ├── 64615 Chemodenervation; facial, trigeminal, cervical spinal, accessory nerves
│ ├── 64616 Chemodenervation; neck muscle(s), excluding laryngeal
│ └── 64617 Chemodenervation; larynx, for spasmodic dysphonia
│
├── 64642 Chemodenervation, 1 extremity; 1-4 muscle(s) (Global: 000)
├── +64643 Chemodenervation, each additional extremity; 1-4 muscle(s) [Add-on]
│
├── ▶▶ 64644 ◀◀ Chemodenervation, 1 extremity; 5 or more muscle(s) ← YOU ARE HERE (Global: 000)
│ └── Primary/base code — must represent the extremity with the MOST muscles injected
├── +64645 Chemodenervation, each additional extremity; 5 or more muscle(s) [Add-on to 64644]
│
├── 64646 Chemodenervation of trunk muscle(s); 1-5 muscle(s) (separate anatomic domain)
└── +64647 Chemodenervation of trunk muscle(s); 6 or more muscle(s) [Add-on]
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 1.77 (verify against current CMS MPFS for applicable year) |
| Practice Expense RVU | 3.54 |
| Malpractice RVU | 0.40 |
| Total RVU | 5.71 |
| Global Period | 000 (0 days) |
| Bilateral Indicator | 0 — not subject to bilateral reduction; each additional extremity uses 64645 or 64643 |
| Assistant Surgeon | ❌ Not payable |
| PC/TC Split | ❌ No — procedure code only (Indicator 0) |
| Modifier -51 Exempt | No |
The muscle count threshold of 5 is the single determinant of which primary code applies. In sessions where multiple extremities are treated with different muscle counts, always assign 64644 as the primary code when at least one extremity receives 5 or more injections — even if that is not the first extremity treated procedurally. The base code should reflect the most extensively treated limb. This maximizes appropriate reimbursement and aligns with CPT parenthetical guidance.
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -RT | Right Side | Identifies the specific extremity as right-sided; not required for payment but strongly recommended for documentation clarity and audit defense |
| -LT | Left Side | Identifies left-sided extremity treatment |
| -25 | Significant, Separately Identifiable E/M | Applied to the E/M code — not 64644 — when a same-day office visit involves evaluation beyond the standard pre-injection assessment; documentation must clearly support a distinct and separately identifiable medical decision-making process |
| -59 | Distinct Procedural Service | When payers attempt to bundle 64644 with a separately reportable procedure; documents distinct anatomic site or independent service |
| -52 | Reduced Services | Procedure partially completed |
| -53 | Discontinued Procedure | Procedure stopped due to patient safety concern; document reason thoroughly |
🩺 Common ICD-10-CM Pairings
Post-Stroke / Acquired Spasticity
| ICD-10 Code | Description | HCC? | HCC Category (v28) | Clinical Notes |
|---|---|---|---|---|
| G81.10 | Spastic hemiplegia affecting unspecified side | ✅ Yes | HCC Motor/Cognitive | Most common post-stroke driver; query for dominant vs. non-dominant when not specified |
| G81.11 | Spastic hemiplegia affecting right dominant side | ✅ Yes | HCC Motor/Cognitive | Right-dominant hemiplegia; most specific when documented |
| G81.12 | Spastic hemiplegia affecting left dominant side | ✅ Yes | HCC Motor/Cognitive | Left-dominant hemiplegia |
| I69.351 | Hemiplegia and hemiparesis following cerebral infarction, right dominant side | ✅ Yes | Stroke Sequelae HCC | Most specific post-stroke sequela code; preferred when etiology is clearly documented as ischemic infarction |
| I69.352 | Hemiplegia and hemiparesis following cerebral infarction, left dominant side | ✅ Yes | Stroke Sequelae HCC | Left-sided post-stroke hemiplegia sequela |
Cerebral Palsy
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G80.0 | Spastic quadriplegic cerebral palsy | ✅ Yes | All four extremities involved; diffuse multi-muscle spasticity per limb is the rule — 64644 is frequently the appropriate primary code for these patients |
| G80.1 | Spastic diplegic cerebral palsy | ✅ Yes | Bilateral lower limb involvement with multi-muscle spasticity patterns; 64644 common for the more extensively treated limb |
| G80.2 | Spastic hemiplegic cerebral palsy | ✅ Yes | Unilateral; when 5+ muscles are injected on the affected side, 64644 is primary |
Systemic Neurological Conditions
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G82.20 | Paraplegia, unspecified | ✅ Yes | HCC Motor/Cognitive |
| G82.50 | Quadriplegia, unspecified | ✅ Yes | HCC Motor/Cognitive |
| G35.- | Multiple sclerosis | ✅ Yes | HCC Demyelinating |
Focal Dystonia
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G24.1 | Genetic torsion dystonia | ❌ No | Hereditary etiology with complex multi-muscle involvement; 5+ muscles per limb is common |
| G24.2 | Idiopathic non-familial dystonia | ❌ No | No identifiable genetic cause; most common focal dystonia category for extensive extremity injections |
CMS LCD Coverage — Spasm of Muscle
| ICD-10 Range | Description | HCC? | Clinical Notes |
|---|---|---|---|
| M62.411-M62.838 | Spasm of muscle, various anatomic sites | ❌ No | Per CMS Billing and Coding Article A57185 (Group 8), this code range supports medical necessity for 64642-64647 when treating spasticity secondary to spastic hemiplegia and hemiparesis; use the most specific anatomic site available |
CMS LCD and MAC Coverage Reminder
Per CMS Billing and Coding Article A57185 (updated March 2026), CPT codes 64642, 64643, 64644, 64645, 64646, and 64647 are covered under Group 15 for spasticity. The ICD-10-CM codes supporting medical necessity span both the neurological condition codes (G80.x, G81.x, G82.x, G35, I69.3xx) and the muscle spasm range (M62.411-M62.838). Always verify the applicable MAC LCD and billing article version for your jurisdiction prior to claim submission, as covered diagnosis lists are subject to periodic updates.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 64644 is not used in the inpatient facility setting —b governs all inpatient facility procedure coding. The blisted here reflect typical DRG assignments when chemodenervation is performed as part of an inpatient rehabilitation or acute care stay, where the principal diagnosis drives DRG assignment entirely. The PCS chemodenervation code itself does not independently trigger a surgical DRG.
Representative DRGs by Principal Diagnosis Category
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 056 | Degenerative Nervous System Disorders with MCC | ~5.9 days | MS, Parkinson’s — high-severity comorbidities |
| 057 | Degenerative Nervous System Disorders without MCC | ~3.4 days | MS or Parkinson’s without qualifying secondary diagnoses |
| 065 | Intracranial Hemorrhage or Cerebral Infarction with MCC | ~5.0 days | Stroke with high-severity comorbidities |
| 066 | Intracranial Hemorrhage or Cerebral Infarction with CC | ~3.6 days | Stroke with moderate CC |
| 559 | Aftercare, Musculoskeletal System & Connective Tissue with MCC | ~4.8 days | Rehabilitation aftercare admissions with high-severity secondary diagnoses |
| 560 | Aftercare, Musculoskeletal System & Connective Tissue with CC | ~3.5 days | Rehabilitation aftercare with CC |
CC/MCC Capture in Neurological Inpatients
Patients admitted for conditions commonly driving spasticity often have co-documented diagnoses carrying CC/MCC weight. Always code the following when clinically documented and supported by the attending’s record:
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
| PCS Code | Full Description | Notes |
|---|---|---|
3E0M3GC | Introduction of Other Therapeutic Substance into Muscle, Percutaneous Approach | Single PCS code for botulinum toxin injection into extremity musculature; body part “M” (Muscle) encompasses all extremity muscles regardless of how many are injected |
PCS Character Analysis — 3E0M3GC
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Root Operation | 0 | Introduction (putting in or on a therapeutic substance) |
| 4 | Body Part | M | Muscle |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | G | Other Therapeutic Substance |
| 7 | Qualifier | C | Other Substance |
PCS Coding Note
Unlike CPT, which distinguishes between 1-4 muscles (64642) and 5 or more muscles (64644), b does not differentiate by muscle count within a body part. The code 3E0M3GC applies regardless of whether 3, 5, or 10 muscles are injected in an extremity. For multi-extremity sessions, most facilities assign one PCS code per session; some assign per-extremity — confirm with your facility’s coding policy before assigning multiple lines for the same body part value.
📝 Coding Examples
Example 1 — Office: Post-Stroke Upper Limb, 6 Muscles, Single Extremity
Clinical Scenario: A 71-year-old female with right-sided ischemic stroke sequelae presents with right upper limb flexor synergy. The physician injects onabotulinumtoxinA into 6 muscles: pectoralis major (50u), biceps brachii (75u), brachialis (25u), pronator teres (25u), flexor carpi radialis (25u), and flexor digitorum superficialis (25u). Total dose: 225 units. EMG guidance used. No separately identifiable E/M.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64644-RT | Chemodenervation, right upper extremity; 6 muscles — 5 or more threshold met |
| CPT 2 | 95874 | Needle EMG guidance; list separately in addition to 64644 |
| Drug | J0585 × 225 | OnabotulinumtoxinA, 225 units documented and administered |
| PDx | I69.351 | Hemiplegia/hemiparesis following cerebral infarction, right dominant side |
Note
Example 2 — Office: Bilateral Lower Extremity, Asymmetric Muscle Counts, CP with Spastic Diplegia
Clinical Scenario: A 16-year-old with spastic diplegic cerebral palsy presents for bilateral lower extremity botulinum toxin. Right lower extremity: gastrocnemius medial head, gastrocnemius lateral head, soleus, tibialis posterior, flexor digitorum longus — 5 muscles. Left lower extremity: gastrocnemius medial head, soleus — 2 muscles. Ultrasound guidance used bilaterally. No separate E/M.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 64644-RT | Primary/base code — right lower extremity; 5 muscles (5 or more threshold); this limb has more muscles and becomes the primary code |
| CPT 2 | 64643-LT | Add-on — left lower extremity; 2 muscles (1-4 threshold); cross-family add-on from 64644 primary |
| CPT 3 | 76942 | Ultrasound guidance; list separately; one unit per session |
| Drug | J0586 × units | Bill total Dysport units administered across both extremities ÷ 5 per billing unit |
| PDx | G80.1 | Spastic diplegic cerebral palsy |
Cross-Family Add-On Rule
When the primary extremity has 5+ muscles (64644) but the additional extremity has only 1-4 muscles, the correct add-on is 64643 — not 64645. The add-on code is chosen based on the muscle count of that specific additional extremity, not the primary. Mixing up 64643 and 64645 for the add-on is one of the most common errors in multi-extremity chemodenervation billing.
Example 3 — Office: Three-Extremity Session, All 5+ Muscles, MS, with Separate E/M
Clinical Scenario: A 55-year-old male with secondary progressive MS presents for quarterly chemodenervation. Right upper extremity: 5 muscles. Left lower extremity: 7 muscles. Right lower extremity: 5 muscles. The physician also documents a separately identifiable E/M — a new urinary urgency complaint is evaluated with distinct history, exam, and clinical decision-making documented separately from the pre-injection spasticity assessment.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 99213-25 | E/M, established patient; -25 on the E/M — documentation must clearly reflect distinct MDM for the urinary complaint beyond the pre-injection assessment |
| CPT 2 | 64644 | Primary/base code — left lower extremity chosen as primary because it has the most muscles (7); assign to the most extensively injected limb |
| CPT 3 | 64645 | Add-on — right upper extremity; 5 muscles (5 or more); first add-on unit |
| CPT 4 | 64645 | Add-on — right lower extremity; 5 muscles; second add-on unit |
| PDx | G35.- | Multiple sclerosis |
Note
Two units of 64645 are correct here — two additional extremities beyond the primary, both meeting the 5 or more threshold. The primary code is assigned to the extremity with the most muscles (left lower, 7 muscles), following CPT parenthetical guidance. The add-ons follow the muscle count of each respective additional limb.
⚠️ Common Coding Pitfalls
-
Assigning 64644 to the wrong extremity: The primary code should always represent the extremity with the most muscles injected, not necessarily the first one treated procedurally. Assigning 64644 to the first extremity injected while a second extremity received more injections results in misapplication of the code hierarchy.
-
Counting injection sites instead of muscles: Multiple needle passes within a single muscle do not constitute multiple muscles. A physician who injects the gastrocnemius at 4 sites has treated 1 muscle. The procedure note must name each distinct muscle; only named, anatomically distinct muscles count toward the 5-muscle threshold for 64644.
-
Reporting 64642 and 64644 for the same extremity: These codes are mutually exclusive per limb per session. When 5 or more muscles are injected in a single extremity, only 64644 is reported — not both 64642 and 64644 on the same line.
-
Incorrectly choosing the add-on code for an asymmetric session: When 64644 is the primary (5+ muscles, first extremity) and a second extremity has only 1-4 muscles, the correct add-on is 64643, not 64645. The add-on code selection is determined by the muscle count of each additional extremity independently.
-
Forgetting the drug J-code: The botulinum toxin (J-code) is always a separate billing line. Omitting it leaves the majority of the encounter’s revenue on the table and is a significant and entirely avoidable billing gap.
-
Applying modifier -50: Per CMS, the bilateral modifier (-50) is not applicable to 64644 (bilateral indicator = 0). Bilateral treatment of two extremities is captured by the primary code + add-on structure, not by modifier -50 on a single line.
📎 Sources
AMA CPT 2025 Professional Edition · CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) · CMS RVU25A Relative Value Files · CMS Billing and Coding Article A57185 — Botulinum Toxin Injections (updated March 2026, Noridian) · CMS Billing and Coding Article A52848 — Botulinum Toxins · NCCI Policy Manual Chapter 11 (Nervous System), CMS 2024-2025 · ICD-10-CM Official Guidelines for Coding and Reporting FY2025 · ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 · RVU Edge CPT 64644 Profile (2026) · Practical Neurology — Botulinum Toxin Billing & Coding Update (April 2026) · Ambu USA — Myoguide CPT Coding Reference · Frontiers in Neurology — Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Resource Use (PMC10427537)